The clinical study will assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid tumor malignancies or lymphoma.
Age: 18 years - 66+
Gender: All
We've found 4 total results for "Triple Negative Breast Neoplasms".
Triple negative breast cancer (TNBC) represents about 15% of breast cancers and is characterized by the lack of expression of estrogen receptor (ER), progesterone receptor (PR), and HER-2 non-amplification. Women with TNBC tend to be younger, African American, and ...
Age: 18 years - 66+
Gender: Female
This is a Phase 1/1b open-label, dose escalation and dose expansion study of CPI-006, a humanized monoclonal antibody (mAb) targeting the CD73 cell-surface ectonucleotidase in adult subjects with select advanced cancers. CPI-006 will be evaluated as a single agent, ...
- Sarcoma
- Endometrial Neoplasms
- Triple Negative Breast Neoplasms
- Carcinoma, Renal Cell
- Squamous Cell Carcinoma of Head and Neck
Age: 18 years - 66+
Gender: All
The purpose of this study is to evaluate the safety and effectiveness of carboplatin compared to the combination of carboplatin and everolimus for the treatment of advanced triple-negative breast cancer (TNBC).
Age: 18 years - 66+
Gender: Female